top of page

Pioneering novel immunotherapies
through AI-led TCR & antibody design

Powered by cutting-edge drug discovery AI & EXPERIMENTAL validation

PARTNERED WITH

Nvidia-Horizontal-Black-Logo2.png
Google-Logo.black2.png
VECTOR labs - black.png
Imperial_College_London_black.png

OUR MISSION

Pioneer the combination of machine and human intelligence to develop the best immunotherapies for cancer patients in urgent need

3

TCR and Antibody specific LLMs fine-tuned/created

3

Pipeline programmes

6

In silico design to lead candidates in six months

HOW CAN WE HELP YOU?

Elevate your drug discovery outcomes.
 

We deliver safer, more precise drug candidates for your pipeline – faster.

How it works

Rapid design & engineering of new candidates and biobetters

Design, optimise and validate TCRs, Antibodies, Bispecifics and VHHs.

 

See how we engineered a TCR to 5 million fold improvement using our EMLy AI. </